1.
Public Health England - Diabetes prevention programmes: evidence review, https://www.gov.uk/government/publications/diabetes-prevention-programmes-evidence-review, (2015).
2.
Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association. Diabetes Care. 31, S61–S78 (2008). https://doi.org/10.2337/dc08-S061.
3.
Carter, P., Khunti, K., Davies, M.J.: Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on? Journal of Nutrition and Metabolism. 2012, 1–6 (2012). https://doi.org/10.1155/2012/847202.
4.
Colberg, S.R., Sigal, R.J., Fernhall, B., Regensteiner, J.G., Blissmer, B.J., Rubin, R.R., Chasan-Taber, L., Albright, A.L., Braun, B.: Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 33, 2692–2696 (2010). https://doi.org/10.2337/dc10-1548.
5.
Dyson, P.A., Kelly, T., Deakin, T., Duncan, A., Frost, G., Harrison, Z., Khatri, D., Kunka, D., McArdle, P., Mellor, D., Oliver, L., Worth, J.: Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetic Medicine. 28, 1282–1288 (2011). https://doi.org/10.1111/j.1464-5491.2011.03371.x.
6.
Gillies, C.L., Abrams, K.R., Lambert, P.C., Cooper, N.J., Sutton, A.J., Hsu, R.T., Khunti, K.: Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 334, 299–299 (2007). https://doi.org/10.1136/bmj.39063.689375.55.
7.
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 346, 393–403 (2002). https://doi.org/10.1056/NEJMoa012512.
8.
The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts, http://link.springer.com/article/10.1007/s10654-009-9405-0/fulltext.html.
9.
Lindstrom, J., Louheranta, A., Mannelin, M., Rastas, M., Salminen, V., Eriksson, J., Uusitupa, M., Tuomilehto, J.: The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 26, 3230–3236 (2003). https://doi.org/10.2337/diacare.26.12.3230.
10.
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Xiao, J.-Z., Cao, H.-B., Liu, P.-A., Jiang, X.-G., Jiang, Y.-Y., Wang, J.-P., Zheng, H., Zhang, H., Bennett, P.H., Howard, B.V.: Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 20, 537–544 (1997). https://doi.org/10.2337/diacare.20.4.537.
11.
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A.D., Vijay, V.: The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 49, 289–297 (2006). https://doi.org/10.1007/s00125-005-0097-z.
12.
Schwarz, P.E., Greaves, C.J., Lindström, J., Yates, T., Davies, M.J.: Nonpharmacological interventions for the prevention of type 2 diabetes mellitus. Nature Reviews Endocrinology. (2012). https://doi.org/10.1038/nrendo.2011.232.
13.
Schwarz, P.E.H.: Public Health Implications: Translation into Diabetes Prevention Initiatives—Four-Level Public Health Concept. Medical Clinics of North America. 95, 397–407 (2011). https://doi.org/10.1016/j.mcna.2010.11.008.
14.
Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Aunola, S., Cepaitis, Z., Moltchanov, V., Hakumaki, M., Mannelin, M., Martikkala, V., Sundvall, J., Uusitupa, M.: Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine. 344, 1343–1350 (2001). https://doi.org/10.1056/NEJM200105033441801.
15.
Screening for type 2 diabetes: literature review and economic modelling. Clinical Governance: An International Journal. 12, (2007). https://doi.org/10.1108/cgij.2007.24812dae.003.
16.
Absetz, P., Oldenburg, B., Hankonen, N., Valve, R., Heinonen, H., Nissinen, A., Fogelholm, M., Talja, M., Uutela, A.: Type 2 Diabetes Prevention in the Real World: Three-year results of the GOAL Lifestyle Implementation Trial. Diabetes Care. 32, 1418–1420 (2009). https://doi.org/10.2337/dc09-0039.
17.
Ackermann, R.T., Finch, E.A., Brizendine, E., Zhou, H., Marrero, D.G.: Translating the Diabetes Prevention Program into the Community. American Journal of Preventive Medicine. 35, 357–363 (2008). https://doi.org/10.1016/j.amepre.2008.06.035.
18.
Chiasson, J.-L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet. 359, 2072–2077 (2002). https://doi.org/10.1016/S0140-6736(02)08905-5.
19.
DeFronzo, R.A., Tripathy, D., Schwenke, D.C., Banerji, M., Bray, G.A., Buchanan, T.A., Clement, S.C., Henry, R.R., Hodis, H.N., Kitabchi, A.E., Mack, W.J., Mudaliar, S., Ratner, R.E., Williams, K., Stentz, F.B., Musi, N., Reaven, P.D.: Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance. New England Journal of Medicine. 364, 1104–1115 (2011). https://doi.org/10.1056/NEJMoa1010949.
20.
Gray, L.J., Yates, T., Davies, M.J., Brady, E., Webb, D.R., Sattar, N., Khunti, K.: Defining Obesity Cut-Off Points for Migrant South Asians. PLoS ONE. 6, (2011). https://doi.org/10.1371/journal.pone.0026464.
21.
Greaves, C.J., Sheppard, K.E., Abraham, C., Hardeman, W., Roden, M., Evans, P.H., Schwarz, P.: Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health. 11, (2011). https://doi.org/10.1186/1471-2458-11-119.
22.
Effect of Valsartan on the Incidence of Diabetes. New England Journal of Medicine. 363, 792–793 (2010). https://doi.org/10.1056/NEJMc1005899.
23.
Schwarz, P.E.H., Gruhl, U., Bornstein, S.R., Landgraf, R., Hall, M., Tuomilehto, J.: Development and Implementation of A European Guideline and Training Standards for Diabetes Prevention-The IMAGE project. Journal of Public Health. 15, 353–360 (2007). https://doi.org/10.1007/s10389-007-0145-x.
24.
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine. 362, 1463–1476 (2010). https://doi.org/10.1056/NEJMoa1001122.
25.
Yates, T., Davies, M., Gorely, T., Bull, F., Khunti, K.: Effectiveness of a Pragmatic Education Program Designed to Promote Walking Activity in Individuals With Impaired Glucose Tolerance: A randomized controlled trial. Diabetes Care. 32, 1404–1410 (2009). https://doi.org/10.2337/dc09-0130.
26.
Yates, T., Wilmot, E.G., Khunti, K., Biddle, S., Gorely, T., Davies, M.J.: Stand up for your health: Is it time to rethink the physical activity paradigm? Diabetes Research and Clinical Practice. 93, 292–294 (2011). https://doi.org/10.1016/j.diabres.2011.03.023.
27.
Steven N Blair: Physical inactivity: the biggest public health problem of the 21st century. British Journal of Sports Medicine. 43, 1–2 (2009).
28.
Frank W. Booth: Waging war on modern chronic diseases: primary prevention through exercise biology. Journal of Applied Physiology. 88, 774–787 (2000).
29.
Church, T.S., Cheng, Y.J., Earnest, C.P., Barlow, C.E., Gibbons, L.W., Priest, E.L., Blair, S.N.: Exercise Capacity and Body Composition as Predictors of Mortality Among Men With Diabetes. Diabetes Care. 27, 83–88 (2004). https://doi.org/10.2337/diacare.27.1.83.
30.
Cordain, L., Gotshall, R., Eaton, S., Eaton, S.: Physical Activity, Energy Expenditure and Fitness: An Evolutionary Perspective. International Journal of Sports Medicine. 19, 328–335 (1998). https://doi.org/10.1055/s-2007-971926.
31.
Hamman, R.F., Wing, R.R., Edelstein, S.L., Lachin, J.M., Bray, G.A., Delahanty, L., Hoskin, M., Kriska, A.M., Mayer-Davis, E.J., Pi-Sunyer, X., Regensteiner, J., Venditti, B., Wylie-Rosett, J.: Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes. Diabetes Care. 29, 2102–2107 (2006). https://doi.org/10.2337/dc06-0560.
32.
Laaksonen, D.E., Lindstrom, J., Lakka, T.A., Eriksson, J.G., Niskanen, L., Wikstrom, K., Aunola, S., Keinanen-Kiukaanniemi, S., Laakso, M., Valle, T.T., Ilanne-Parikka, P., Louheranta, A., Hamalainen, H., Rastas, M., Salminen, V., Cepaitis, Z., Hakumaki, M., Kaikkonen, H., Harkonen, P., Sundvall, J., Tuomilehto, J., Uusitupa, M.: Physical Activity in the Prevention of Type 2 Diabetes: The Finnish Diabetes Prevention Study. Diabetes. 54, 158–165 (2005). https://doi.org/10.2337/diabetes.54.1.158.
33.
Norris, S.L., Zhang, X., Avenell, A., Gregg, E., Schmid, C.H., Lau, J.: Long-term non-pharmacological weight loss interventions for adults with prediabetes. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, Chichester, UK (1996). https://doi.org/10.1002/14651858.CD005270.
34.
TELFORD, RICHARD D.: Low Physical Activity and Obesity: Causes of Chronic Disease or Simply Predictors? Medicine & Science in Sports & Exercise. 39,.
35.
Umpierre, D.: Physical Activity Advice Only or Structured Exercise Training and Association With HbA                              Levels in Type 2 Diabetes. JAMA. 305, (2011). https://doi.org/10.1001/jama.2011.576.
36.
Yates, T., Khunti, K., Troughton, J., Davies, M.: The role of physical activity in the management of type 2 diabetes mellitus. Postgraduate Medical Journal. 85, 129–133 (2009). https://doi.org/10.1136/pgmj.2008.067900.